LEXINGTON, Mass and London -- Concert Pharmaceuticals and GlaxoSmithKline (NYSE: GSK) announced today that they will collaborate to develop and commercialize deuterium-containing medicines. The deal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback